Peptides are now part of wellness culture, gym conversations and TikTok explainers

A pulled muscle, a stubborn injury, chronic inflammation, and a quick scroll online will tell you there’s a shortcut for all of it. BPC-157 for repair. TB-500 for recovery. GHK-Cu for regeneration. Each one packaged as a targeted fix for a very specific biological problem.
It starts to sound like a catalogue of solutions built for every weakness the body can have.
There’s a peptide for all the problems, if you look hard enough.
The rise of peptides has exploded far beyond medical clinics and research labs. They are now part of wellness culture, biohacking communities, gym conversations and TikTok explainers promising faster healing and biological ‘optimisation’.
Yet beneath the hype lies a more complicated reality. Some peptide-based therapies are already firmly embedded in modern medicine, while others sit in a grey zone, scientifically intriguing, widely discussed online, but still lacking large-scale human trials.
And that raises the uncomfortable question: Just because peptides can influence the body, should everyone be using them?
As the most basic explanation, Peptides are short chains of amino acids that act as biological messengers, signalling cells to activate, repair, or regenerate, as Dr Maurizio Viel, plastic surgeon at Cornerstone Clinic, Dubai, explains.
Unlike supplements, which mostly provide nutrients or raw materials, peptides actively instruct the body. They send targeted signals: Repair tissue, regulate inflammation, influence metabolism, stimulate collagen or affect hormone pathways. Perhaps, this precision is what renders them so attractive. "This specificity is what makes peptide therapy a clinically credible tool in regenerative and aesthetic medicine, not a trend, but a reflection of how the body naturally communicates at a cellular level," elaborates Dr Viel.
As Abhinav Malhotra, personal trainer and founder of AbhiFit, that specialises in strength training, metabolic health, pain rehab and performance optimisation, explains, “Unlike many drugs that broadly affect the body, peptides bind to specific receptors, almost like a key fitting into a lock, triggering very specific biological responses.”
And so, peptides aren’t a new, fringe wellness invention. In fact, many, are already a part of everyday medicine. Insulin, used for diabetes, is a peptide, along with major obesity and metabolic drugs dominating healthcare conversations today, including Ozempic and Mounjaro.
They’re already mainstream medicine. Dr. Anant Vinjamoori, Chief Medical Officer at Valeo Health, Dubai notes, "The question is not whether peptides can work. They clearly can. The question is which newer peptides deserve broader clinical use, and what evidence we need to guide that responsibly.”
Across interviews, clinicians repeatedly pointed to a handful of peptides now dominating wellness conversations online:
BPC-157: Frequently promoted for injury recovery, tendon repair, gut healing and inflammation reduction.
TB-500 (Thymosin Beta-4): Associated with wound healing, tissue repair and cellular regeneration.
GHK-Cu: A copper peptide commonly discussed in anti-ageing and skincare circles for collagen production and skin elasticity.
Ipamorelin and CJC-1295: A growth hormone-releasing peptides often promoted for muscle preservation, recovery and ageing support.
MOTS-c: An emerging peptide drawing attention for metabolic and mitochondrial health.
Selank and Semax: Peptides linked to stress regulation and cognitive function.
The promises surrounding them can sound almost futuristic: Accelerated healing, reduced inflammation, improved body composition, younger-looking skin, sharper cognition.
And according to clinicians, some of the science behind those claims is not entirely fantasy. Yet, it needs to be treated with care and a lot of nuance.
When it comes to medical explanations, the answer is not always straightforward. And definitely, not the quick fix that people need.
To put it best, Dr. Vinjamoori and Dr Karima Arroud, Functional Medicine practitioner at Wellth explain, is that there is signal, but the evidence is uneven. Several peptides have shown strong results in laboratory and animal studies. BPC-157 and TB-500, for instance, have demonstrated effects related to tissue repair, collagen formation, angiogenesis and inflammation modulation in preclinical research. TB-500 also has potential in wound healing, cellular migration and inflammation control.
Meanwhile, GHK-Cu appears to be among the better-supported peptides in aesthetic medicine. “GHK-Cu and Matrixyl show measurable improvements in skin density, elasticity, and fine lines in peer-reviewed studies,” says Dr. Viel.
Even doctors who are cautious about peptide hype acknowledge the biological rationale is compelling. “Peptides don’t override biology, they enhance and signal existing processes,” says Dr. Arroud. “That's why even early-stage data is so compelling.” The distinction matters. Many researchers believe peptides are attracting attention precisely because they work with pathways the body already uses.
However that being said, the enthusiasm has moved faster than evidence. “Many of these peptides do not yet have strong randomised controlled human trials for the uses being marketed,” Dr. Vinjamoori cautions. “That does not mean they do not work. It means the field has outgrown the evidence base.”
In other words: Promising does not automatically mean proven.
The gap between hype and evidence becomes especially visible online, where peptide “stacking” has become increasingly popular in biohacking communities. One of the most talked-about combinations is the so-called “Wolverine stack”, named after the fast-healing X-Men character. It typically combines BPC-157 with TB-500, both promoted for recovery and tissue repair.
Yet scientific evidence remains limited. A recent review by researchers Dan Cushman, a sports medicine doctor at the University of Utah and his colleagues found that while BPC-157 is marketed as influencing pathways linked to blood vessel formation, muscle repair and inflammation, most supporting data still comes from rodent studies. The review, titled Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing, identified only three small pilot studies involving humans.
Other combinations have emerged too. Some users add GHK-Cu and KPV in what online communities call 'glow' or 'KLOW' stacks, claiming benefits ranging from collagen regeneration to reduced inflammation. While GHK-Cu is already used in topical anti-ageing skincare, experts note that injectable versions raise greater safety concerns, particularly around impurities and immune reactions.
As clinicians point out, people are increasingly looking for instant solutions, quick fixes for chronic inflammation, fatigue, slow recovery, visible ageing, stubborn weight gain and muscle loss. For many of these concerns, traditional medicine often feels slow to respond or offers limited short-term answers, explains Dr Arroud.
The success of GLP-1 drugs like semaglutide and tirzepatide, transformed public perception of peptide-based medicine almost overnight. “The GLP-1 drugs changed the public’s imagination, says Dr. Vinjamoori. “They showed that peptide-based therapies can produce dramatic, measurable results.”
Social media did the rest. Fitness influencers, biohackers and wellness creators began discussing peptides as the next frontier of human optimisation. Suddenly, conversations once confined to clinics and research communities were being repackaged into short-form videos promising faster healing and better bodies.
Peptides sit at the intersection of cutting-edge science and human desire for faster results, explains Malhotra. Social media has amplified this, often far ahead of science.
Dr. Viel believes another reason for their popularity is that people increasingly want interventions that feel biologically aligned rather than harsh or invasive. “Patients today are also more sophisticated; they actively seek approaches that work with their biology rather than against it,” he says.
Still, experts repeatedly stress that the internet often erases an important distinction: Medically supervised peptide therapy versus self-experimentation with unregulated substances purchased online.
And that distinction may be the difference between legitimate treatment and dangerous misuse.
The word ‘peptides’ sound harmless, or even natural for that matter. Yet, doctors warn that biologically active compounds are still biologically active compounds. “The risks are real and consistently underestimated,” says Dr. Viel.
One major issue is quality control. And, as Dr Arroud points out, the primary concern is not the concept of peptides themselves, but the context in which they are used. Many peptides sold online are not pharmaceutical grade, meaning purity, dosage and manufacturing standards may be questionable. The concerns include contaminated or mislabeled products, poor sterile technique, infection, hormone disruption, unmonitored IGF-1 changes, missed contraindications, and no clear way to measure benefit or harm, says Dr. Vinjamoori.
Worse, there is also the risk of self-diagnosis. Someone treating what they assume is inflammation or ageing fatigue may actually have an underlying medical condition requiring proper care. Peptides can also affect hormone pathways, metabolism and organ systems in ways that require monitoring.
Dr Viel adds: Without a proper medical assessment, there is no safe basis for any protocol. The wrong peptide or dose can disrupt hormonal balance or suppress the body's natural production. He emphasises: The blood tests and ongoing monitoring are essential during treatment to ensure kidney, liver and lipid markers remain stable. "Being naturally occurring does not mean risk-free, and no online community is a substitute for a physician who knows your full health history. Its important during the treatment to do regular blood tests to check if all the parameters are in the normal range and there are no issues with any organ like kidney, liver and lipid profile or over dosage of GHK-Cu."
Even Malhotra, who openly discusses experimenting with peptides himself, stresses caution. “With clients, my approach is far more selective,” he says. “I only recommend peptides after carefully evaluating the risks and benefits, often alongside medical professionals.”
He also points to another overlooked issue: Overuse. Over time, receptors can become less sensitive, meaning higher doses are needed for the same effect,” he explains. “This is where smarter strategies like minimal effective dosing and cycling become important.”
The reality is more nuanced than either side admits. Peptides are not miracle cures, but dismissing them entirely would ignore a rapidly evolving area of medicine that already includes some of the world’s most important therapies.
Doctors say the real challenge now is separating legitimate science from hype, anecdote and aggressive online marketing. “The right stance is curiosity with discipline,” says Dr. Vinjamoori. “Some of these may become important tools. The job now is to separate durable clinical signal from noise.”
For now, peptides occupy a middle ground. They do hold scientific promise, and are medically useful in some contexts, yet, uncertain in others.
Yet, all experts can agree on: They are moving the conversation around ageing, recovery and performance.
But experts agree on one final point, perhaps the least glamorous truth in the entire peptide boom. “Peptides are not magic,” says Malhotra. “They are tools. And like any powerful tool, their value depends entirely on how intelligently they are used.”
Or, as he puts it more bluntly: “For most people, the real transformation still comes from mastering the basics, training, nutrition, sleep, and consistency. Everything else, including peptides, is just an upgrade, not the foundation.”
Network Links
GN StoreDownload our app
© Al Nisr Publishing LLC 2026. All rights reserved.